文献速递心律失常

利用商用智能手表被动检测心房颤动

Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch.
PubMed 文献 · JAMA Cardiol · 2018-01-01

本研究基于Health eHeart远程队列9750名参与者及51名接受心脏电复律患者的智能手表数据,开发并验证了一种深度神经网络算法,用于被动检测心房颤动(AF)。以12导联心电图(ECG)为参考标准,算法在外部验证队列中检测AF的C统计量为0.97,敏感度98.0%,特异度90.2%。在依赖自我报告持续性AF的探索性分析中,C统计量为0.72,敏感度67.7%,特异度67.6%。

要点

  • 智能手表光电容积脉搏波结合深度神经网络可被动检测AF。
  • 以12导联ECG为参考,外部验证C统计量0.97,敏感度98.0%,特异度90.2%。
  • 基于自我报告的探索性验证性能较低,C统计量0.72。

核心结论

  • 概念验证研究显示,智能手表光电容积脉搏波联合深度神经网络能被动检测AF,但对照标准ECG时敏感度和特异度有所损失。

研究设计与样本

  • 多国心血管远程队列研究,在美国加州大学旧金山分校协调开展,使用智能手表获取心率和步数数据用于算法开发。
  • 纳入2016年2月至2017年3月期间Health eHeart研究的9750名参与者及51名接受心脏电复律的患者。
  • 深度神经网络采用启发式预训练方法,无需手动标注训练数据即可近似R-R间期表示。
  • 以12导联ECG诊断的AF为参考标准,在独立的心脏电复律患者队列中进行验证;另以自我报告的持续性AF为参考标准,在门诊参与者中开展探索性验证。

主要发现

  • 远程队列9750名参与者中包括347名AF患者,6143名(63.0%)为男性,平均(SD)年龄42(12)岁。
  • 在51名接受心脏电复律患者的外部验证队列中,对照12导联ECG诊断的AF,C统计量为0.97(95%CI,0.94-1.00;P < .001),敏感度98.0%,特异度90.2%。
  • 在依赖自我报告持续性AF的门诊参与者探索性分析中,C统计量为0.72(95%CI,0.64-0.78),敏感度67.7%,特异度67.6%。

临床怎么用

  • 智能手表光电容积脉搏波数据结合深度神经网络可用于AF的被动筛查,但需注意对照标准ECG时敏感度和特异度有所下降。
  • 该算法的临床最佳应用场景尚需进一步研究确定。

局限性

  • 本研究为概念验证研究,外部验证队列样本量较小(51名接受心脏电复律患者)。
  • 探索性分析依赖自我报告的持续性AF作为参考标准,而非ECG确诊。
  • 算法在更广泛人群中的性能仍需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Atrial fibrillation (AF) affects 34 million people worldwide and is a leading cause of stroke. A readily accessible means to continuously monitor for AF could prevent large numbers of strokes and death. OBJECTIVE: To develop and validate a deep neural network to detect AF using smartwatch data. DESIGN, SETTING, AND PARTICIPANTS: In this multinational cardiovascular remote cohort study coordinated at the University of California, San Francisco, smartwatches were used to obtain heart rate and step count data for algorithm development. A total of 9750 participants enrolled in the Health eHeart Study and 51 patients undergoing cardioversion at the University of California, San Francisco, were enrolled between February 2016 and March 2017. A deep neural network was trained using a method called heuristic pretraining in which the network approximated representations of the R-R interval (ie, time between heartbeats) without manual labeling of training data. Validation was performed against the reference standard 12-lead electrocardiography (ECG) in a separate cohort of patients undergoing cardioversion. A second exploratory validation was performed using smartwatch data from ambulatory individuals against the reference standard of self-reported history of persistent AF. Data were analyzed from March 2017 to September 2017. MAIN OUTCOMES AND MEASURES: The sensitivity, specificity, and receiver operating characteristic C statistic for the algorithm to detect AF were generated based on the reference standard of 12-lead ECG-diagnosed AF. RESULTS: Of the 9750 participants enrolled in the remote cohort, including 347 participants with AF, 6143 (63.0%) were male, and the mean (SD) age was 42 (12) years. There were more than 139 million heart rate measurements on which the deep neural network was trained. The deep neural network exhibited a C statistic of 0.97 (95% CI, 0.94-1.00; P < .001) to detect AF against the reference standard 12-lead ECG-diagnosed AF in the external validation cohort of 51 patients undergoing cardioversion; sensitivity was 98.0% and specificity was 90.2%. In an exploratory analysis relying on self-report of persistent AF in ambulatory participants, the C statistic was 0.72 (95% CI, 0.64-0.78); sensitivity was 67.7% and specificity was 67.6%. CONCLUSIONS AND RELEVANCE: This proof-of-concept study found that smartwatch photoplethysmography coupled with a deep neural network can passively detect AF but with some loss of sensitivity and specificity against a criterion-standard ECG. Further studies will help identify the optimal role for smartwatch-guided rhythm assessment.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Tison GH, Sanchez JM, Ballinger B, et al. Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch. JAMA Cardiol. 2018. PMID: 29562087. doi:10.1001/jamacardio.2018.0136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。